» Articles » PMID: 12085360

Androgen Receptor Exon 1 CAG Repeat Length and Risk of Hepatocellular Carcinoma in Women

Overview
Journal Hepatology
Specialty Gastroenterology
Date 2002 Jun 27
PMID 12085360
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The androgen receptor (AR) gene is localized on chromosome X, and shorter CAG repeats in exon 1 of the AR gene were recently suggested to increase hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) risk among men. To examine whether the relationship between the AR-CAG repeats and HCC was also evident among women, we conducted a case-control study in Taiwan. The number of AR-CAG repeats was determined for 238 women with HCC and 354 unrelated control subjects (comprising 188 first-degree and 166 nonbiological relatives) selected from female relatives of patients with HCC. Women harboring 2 AR alleles with more than 23 CAG repeats had an increased risk of HCC (age-adjusted odds ratio [OR], 1.82; 95% CI, 1.06-3.14), compared with women with only short alleles or a single long allele. The association between harboring 2 AR alleles containing longer CAG repeats and HCC was more striking among HBV carriers (age-adjusted OR for more than 22 repeats, 2.23; 95% CI, 1.14-4.34) and particularly prominent among HBV carriers under age 53 years (age-adjusted OR, 3.16; 95% CI, 1.13-8.82). When CAG repeats were analyzed as a continuous variable, the increase in HCC risk associated with each incremental repeat in the shorter of 2 alleles in a given genotype was statistically significant among women with a first-degree relative with HCC (age-adjusted OR, 1.18; 95% CI, 1.01-1.37). No such relationship was detected among women without the family history. In conclusion, our observations suggest that the AR-CAG alleles may contribute to HCC predisposition among women through a mechanism different from that for men.

Citing Articles

The androgen receptor as an emerging target in hepatocellular carcinoma.

Kanda T, Yokosuka O J Hepatocell Carcinoma. 2016; 2:91-9.

PMID: 27508198 PMC: 4918288. DOI: 10.2147/JHC.S48956.


Genetic variations in the one-carbon metabolism pathway genes and susceptibility to hepatocellular carcinoma risk: a case-control study.

Zhang H, Liu C, Han Y, Ma Z, Zhang H, Ma Y Tumour Biol. 2014; 36(2):997-1002.

PMID: 25318605 DOI: 10.1007/s13277-014-2725-z.


Association of androgen receptor exon 1 CAG repeat length with risk of hepatocellular carcinoma: a case-control study.

Li K, Zhong C, Wang J, Wang B, He J, Bi J Tumour Biol. 2014; 35(12):12519-23.

PMID: 25217983 DOI: 10.1007/s13277-014-2570-0.


Impact of sex on the survival of patients with hepatocellular carcinoma: a Surveillance, Epidemiology, and End Results analysis.

Yang D, Hanna D, Usher J, LoCoco J, Chaudhari P, Lenz H Cancer. 2014; 120(23):3707-16.

PMID: 25081299 PMC: 9191612. DOI: 10.1002/cncr.28912.


Androgen receptor signaling in hepatocellular carcinoma and pancreatic cancers.

Kanda T, Jiang X, Yokosuka O World J Gastroenterol. 2014; 20(28):9229-36.

PMID: 25071315 PMC: 4110552. DOI: 10.3748/wjg.v20.i28.9229.